Category: CovidienSyndicate content

Covidien details fiscal 2014 outlook

September 13, 2013 by Brad Perriello

Covidien issues guidance for its fiscal 2014 sales and earnings.

Covidien details fiscal 2014 outlook

Covidien (NYSE:COV) CFO Charles Dockendorff gave investors a look at what the medical device company expects to see for its fiscal 2014 results.

Speaking at Mansfield, Mass.-based Covidien's annual investor meeting, Dockendorff said net sales for FY2014 are expected to grow between 2% and 5% over fiscal 2013.

Medtech trends: The most talked about device makers in August 2013

September 4, 2013 by Arezu Sarvestani

MassDevice.com looks at the internet chatter surrounding the medical device industry with some of most searched-for companies of the last month.

Medtech trends: The most talked about device makers in August 2013

Click to enlarge.

MassDevice.com looked at some of the most talked-about medical device companies, based on trends in U.S. Google searches for the last 30 days.

South Korea is a "key market" in Covidien's global strategy

August 27, 2013 by Arezu Sarvestani

Covidien launches a $21 million innovation center in South Korea, a country the medical device giant calls key to its international plans.

Covidien launches $21M R&D center in South Korea

Massachusetts medical device maker Covidien (NYSE:COV) is opening the doors on a new Center of Innovation in South Korea, a country that the company calls "a key market in our global strategy."

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Covidien recalls flush syringes

August 20, 2013 by Sony Salzman

Covidien warns customers in the U.S. and Bermuda that some of its Monoject syringes were mislabeled and not properly sterilized, prompting the company to recall 6 lots of the device.

Covidien recalls flush syringes

Covidien (NYSE:COV) recalled some lots of its Monoject syringes after discovering a sterilization mishap and labeling problem.

The issues affected 6 lots in shipments that went out to customers in the U.S. and Bermuda, the Mansfield, Mass.-based medical products giant said.

Jury hands Covidien's ev3 subsidiary a possible $275M loss

August 13, 2013 by Brad Perriello

A Delaware state jury finds that Covidien's ev3 subsidiary broke its deal for a $175 million milestone payment to Appriva Medical, awarding the milestone nut plus interest.

Jury hands Covidien's ev3 subsidiary a possible $265M loss

Covidien (NYSE:COV) is on the hook for a $175 million milestone owed by subsidiary ev3 Inc. to a company it acquired 11 years ago, plus another possible $100 million in interest, after a Delaware jury's decision last May.

CAS Medical wins a legal round against Covidien's Nellcor

August 12, 2013 by Brad Perriello

A federal judge tosses 1 count of a patent infringement lawsuit filed by Covidien's Nellcor subsidiary against CAS Medical over patient monitoring technology.

MassDevice.com Legal News

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Boston Scientific, Covidien get in on SetPoint Medical's $27M round

August 8, 2013 by Brad Perriello

SetPoint Medical raises $27 million, including contributions from Boston Scientific, Covidien and GlaxoSmithKline's new venture investing arm.

Boston Scientific, Covidien get in on SetPoint Medical's $27M round

SetPoint Medical said Boston Scientific (NYSE:BSX) and Covidien (NYSE:COV) were among the participants in a $27 million funding round.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp